2023-03-25 07:51:54 ET
Summary
- An acquisition spree has produced a host of problems, costs, write-offs, a collapse in gross margins and profits, cash bleed, and significant dilution.
- While only the evo and Sexton acquisitions have been a real success, the problems at some of the others now seem to be largely in the rearview mirror.
- With most of the growth automatically coming from existing customers and the CGT market still in the early innings, the company is set to be a long-term compounder.
For further details see:
BioLife Solutions Is Set To Finally Absorb Its Acquisitions